Discovery and Optimization of Triazolopyrimidinone Derivatives as Selective NLRP3 Inflammasome InhibitorsDavid Harrison, Alan P. Watt, Jane Scanlon et al.|ACS Medicinal Chemistry Letters|2022Cited by 23